Osi Momoh is an expert on corporate finance and accounting, bonds, trading, cryptocurrency, and much more. Osi has 10+ years of experience in the investment industry, having served as a client-facing ...
The current drug development pipeline is time-consuming, costly and inefficient. To better model interactions between pharmaceuticals and human physiology and, thus, increase the likelihood of drug ...